97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2012-003974-18-BG
(EUCTR)
18/01/201307/11/2012A Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects with Mild to Moderate Ulcerative ColitisA Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects with Mild to Moderate Ulcerative Colitis Mild to Moderate Ulcerative Colitis
MedDRA version: 16.0;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Code: VB-201
INN or Proposed INN: Not applicable
Vascular Biogenics Ltd.NULLNot RecruitingFemale: yes
Male: yes
110Hungary;Bulgaria
2NCT01839214
(ClinicalTrials.gov)
January 201321/4/2013A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative ColitisA Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects With Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: VB-201 160mg;Drug: PlaceboVascular Biogenics Ltd. operating as VBL TherapeuticsNULLCompleted18 YearsN/ABoth112Phase 2Bulgaria;Hungary;Poland
3EUCTR2012-003974-18-HU
(EUCTR)
10/12/201228/09/2012Study to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects with Mild to Moderate Ulcerative ColitisA Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects with Mild to Moderate Ulcerative Colitis Mild to Moderate Ulcerative Colitis
MedDRA version: 16.0;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Code: VB-201
INN or Proposed INN: Not applicable
Vascular Biogenics Ltd.NULLNot RecruitingFemale: yes
Male: yes
110Hungary;Bulgaria